Discover the latest advancements from the EAACI 2023 Congress in Hamburg, featuring three insightful posters on the Basophil Activation Test. Topics include validation studies, technical cut-offs, and automated gating strategies.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
From gastroenterology to neuroimmunology, read the newest developments from BÜHLMANN in our posters presented at the WorldLab 2024!
During ECCO 2024, held from February 21st to 24th, international IBD specialists came to Stockholm to present the latest news in IBD care. In this setting, our colleagues Oliver Dähn and Christian Reinhard had the privilege of presenting the following two posters: Poster 1: P437 - Feasibility study of a Point-of-Care assay for rapid
Continue Reading →
Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.
Social Links